Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Update: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) [Phase 3]
Phase 3 clinical trial update evaluating durvalumab in combination with chemotherapy as first-line treatment for advanced biliary tract canc…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) [Phase 3]
Phase 3 trial evaluating durvalumab in combination with chemotherapy as first-line treatment for advanced biliary tract cancer. The study is…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer [Phase 3]
A Phase 3 trial evaluating trastuzumab deruxtecan-based therapy with rilvegostomig versus standard of care for advanced HER2-expressing bili…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II clinical trial is evaluating iparomlimab and tuvonralimab (QL1706) in combination with albumin-bound paclitaxel and lenvatinib as…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II randomized trial comparing SLOG versus GC in locally advanced or metastatic biliary tract cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer [Phase 1]
Phase 1 trial evaluating Emavusertib (CA-4948) in combination with cisplatin, gemcitabine, and durvalumab in untreated advanced or metastati…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer [Phase 2]
A Phase 2 study evaluating SHR-A1904 for biliary tract cancer is currently recruiting after prior systemic treatment failure.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of a combination therapy—gemcitabine/cisplatin (GemCis) with trastuzumab and …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer [Phase 3]
Phase 3 trial evaluating zanidatamab plus standard-of-care versus standard-of-care alone in advanced HER2-positive biliary tract cancer; the…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
This clinical trial update reports activity of regorafenib in combination with chemotherapy in patients with advanced biliary tract cancer a…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
A Phase Ib/II trial evaluating nanoliposomal irinotecan (nal-IRI) in combination with nivolumab as second-line therapy for advanced biliary …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab plus apatinib in combination with GEMOX for locally advanced biliary tract cancer; the…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC [Phase 2]
Phase 2 trial update for SHR-1210 in combination with Apatinib or chemotherapy in advanced hepatocellular carcinoma or biliary tract cancer;…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. [Phase 2]
Phase 2 trial evaluating nivolumab plus relatlimab with gemcitabine/cisplatin as first-line treatment for advanced biliary tract cancer; the…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for advanced biliary tract carcinoma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC [Phase 2]
A Phase 2 trial evaluating adjuvant therapy after surgical resection in biliary tract cancer using a three-drug regimen of capecitabine, len…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Durvalumab (Imfinzi) is studied in a Japan post-marketing surveillance PMS for biliary tract cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
The PERSUASION registry, a prospective German platform for biliary tract cancers including gallbladder carcinoma, has completed its expanded…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) [Phase 1, Phase 2]
Phase 1/2 BilT-04 trial evaluating gemcitabine and cisplatin with or without CPI-613 (devimistat) for advanced unresectable biliary tract ca…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating GEN-001 in combination with pembrolizumab for advanced biliary tract cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase IIb randomized trial of immune checkpoint inhibitor-based maintenance therapy for advanced biliary tract cancer; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
This completed clinical trial evaluates portal vein stenting for malignant obstruction, reporting on feasibility and safety and detailing ob…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus lenvatinib in previously treated patients with select solid tumors; results on efficacy and safe…